Moderna launches clinical trial testing whether its COVID-19 vaccine leads to miscarriages or stillbirths in pregnant women or birth defects in newborns despite thousands of mothers-to-be receiving the
Two medications have proven to be most effective in keeping blood glucose levels within a target range while managing type 2 diabetes, a disease that affects more than
The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of
A randomized double-blind controlled trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the treatment arm was half the rate
Thursday, December 10, 2020 – Data from 43,448 participants, half of whom received BNT162b2 and half of whom received placebo, showed that the vaccine candidate was well tolerated
CAMBRIDGE, Mass.–(BUSINESS WIRE) December 5, 2020 — Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced new clinical data
COVID-19 (coronavirus) patients who were administered a novel antibody had fewer symptoms and were less likely to require hospitalization or emergency medical care than those who did not
Eli Lilly ends paused trial of antibody drug and remdesivir after the NIH found the combo failed to help recovery of hospitalized patients Eli Lilly & Co and
Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
